Mylan Specialty has expertise in the development of unit dose oral inhalation products for nebulization. Oral inhalation products are aqueous-based solutions or suspensions that are aerosolized for lung delivery using devices called nebulizers. Unit dose vials for nebulization are formed, filled and hermetically sealed under aseptic conditions in one continuous operation in a state-of-the-art manufacturing facility at Mylan Specialty.
Mylan Specialty's Pharmaceutical Development scientists also evaluate the performance of the formulations using state of art equipment. Scientists in Pharmaceutical Development collaborate with others in Analytical Development, Regulatory Affairs, Marketing and Manufacturing to develop products that meet regulatory requirements and are also patient friendly. From powdered drug particles to fine mists, our scientists do it all.
Formulation development scientists conduct studies to optimize stability of product. Our scientists assure compatibility of the formulation with package components. Mylan Specialty is taking steps to broaden its product portfolio and our scientists are getting involved in the development of other drug delivery systems such as metered-dose inhalers, dry powder inhalers and novel nebulization approaches.